🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseMASH resolution without worsening fibrosis — looking for input Page 8

MASH resolution without worsening fibrosis — looking for input

PeptideSynthNJ Wed, Jul 2, 2025 at 8:50 AM 40 replies 1,673 viewsPage 8 of 8
tyler_CSCS
Member
567
2,567
Jun 2024
Phoenix, AZ
Oct 31, 2025 at 1:34 PM#36
DoseLogDan said:
Practical: whatever you change, write down the date and the reason.

Agreed on the substance. I would put less weight on the timescale, because two months of anything is not enough to distinguish a trend from a wobble.

Happy to go further on any of that.

4 2sean_dublin, hannah_MT, Dr.SportsMedIN and 1 other
Reply Quote Save Share Report
MikeKY_noInsulin
Member
267
1,234
Oct 2024
Louisville, KY
Nov 7, 2025 at 3:43 AM#37
DoseLogDan said:
Practical: whatever you change, write down the date and the reason.

Genuinely useful, thank you. I had the facts and not the framework. Printing the relevant bit and taking it with me.

5 3hannah_MT, Dr.SportsMedIN, amy_econ_NJ and 2 others
Reply Quote Save Share Report
Dr.CardioMD
VIP Member
2,678
14,567
Dec 2023
Cleveland, OH
Nov 13, 2025 at 5:48 PM#38

Clinical perspective, offered as context rather than as advice. Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third retelling.

Ask again with the specifics and you will get a better answer than this one.

6 4tony_orlando, Dr.NephBHM_UK, kim_atl_prep and 3 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
BiostatsBrad
Member
456
2,345
Jul 2024
Durham, NC
Nov 20, 2025 at 7:50 AM#39
Dr.CardioMD said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

Can confirm. Same sequence, different timescale. I had assumed I was the exception until I read this.

Last edited: Nov 20, 2025 at 8:50 AM
7 5james_edin, FranDenver, Dr.BariatricHTX and 4 others
Reply Quote Save Share Report
Dr.NephBHM_UK
Member
456
2,123
Jun 2024
Birmingham, UK
Nov 26, 2025 at 9:48 PM#40
Dr.CardioMD said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

There is a second half to this that has not been said yet. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

Last edited: Nov 27, 2025 at 3:48 AM
29 2PeptideChemSF, A1cHero_PHX, Dr.RenalNash and 26 others
Reply Quote Save Share Report
1678

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register